Metabolic effects of telmisartan in subjects with abdominal obesity: a prospective randomized controlled trial.

about

Modulation of glucose metabolism by the renin-angiotensin-aldosterone system Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications

P2860

Q27026157-7ADBDC7B-50E6-405F-BB3B-583C5FCC2FCA Q57488993-A34D1AE5-7AF3-456C-88D2-BF78A088FCBC

P2860

Metabolic effects of telmisartan in subjects with abdominal obesity: a prospective randomized controlled trial.

Item

http://www.wikidata.org/entity/Q45378652

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Metabolic effects of telmisart ...... e randomized controlled trial.

@en

Metabolic effects of telmisart ...... e randomized controlled trial.

@nl

type

Item

label

Metabolic effects of telmisart ...... e randomized controlled trial.

@en

Metabolic effects of telmisart ...... e randomized controlled trial.

@nl

prefLabel

Metabolic effects of telmisart ...... e randomized controlled trial.

@en

Metabolic effects of telmisart ...... e randomized controlled trial.

@nl

P1476

Metabolic effects of telmisart ...... e randomized controlled trial.

@en

P2093

Arya M Sharma

http://www.w3.org/2001/XMLSchema#string

Nina Singh

http://www.w3.org/2001/XMLSchema#string

Sonia S Anand

http://www.w3.org/2001/XMLSchema#string

Suzana Damjanovic

http://www.w3.org/2001/XMLSchema#string

V Tony Chetty

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study.

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Telmisartan: a review of its use in hypertension.

Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study.

Methods for clinical assessment of insulin sensitivity and beta-cell function.

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator.

Abdominal obesity and metabolic syndrome.

P304

54-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08037051.2013.791411

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salim Yusuf

Hertzel C. Gerstein

P577

2013-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23731019

http://www.w3.org/2001/XMLSchema#string

Metabolic effects of telmisartan in subjects with abdominal obesity: a prospective randomized controlled trial.

about

P2860

P2860

Metabolic effects of telmisartan in subjects with abdominal obesity: a prospective randomized controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698